Literature DB >> 22644171

Migraine and small vessel diseases.

E Agostoni1, A Rigamonti.   

Abstract

It is remarkable that migraine is a prominent part of the phenotype of several genetic vasculopathies affecting small cerebral vessels, including cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, retinal vasculopathy with cerebral leukodystrophy and hereditary infantile hemiparesis, retinal arteriolar tortuosity and leucoencephalopathy. Moreover, several studies have reported an association between migraine and white matter lesions or clinically silent infarct-like abnormalities in the posterior circulation. In this review, we focus on genetic vasculopathies associated with migraine and speculate about the pathophysiological mechanism that can explain this comorbidity.

Entities:  

Mesh:

Year:  2012        PMID: 22644171     DOI: 10.1007/s10072-012-1041-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

Review 1.  CADASIL and migraine: A narrative review.

Authors:  Michael K Liem; Saskia A J Lesnik Oberstein; Jeroen van der Grond; Michel D Ferrari; Joost Haan
Journal:  Cephalalgia       Date:  2010-11       Impact factor: 6.292

2.  Impaired endothelial function of forearm resistance arteries in CADASIL patients.

Authors:  Anna Stenborg; Hannu Kalimo; Matti Viitanen; Andreas Terent; Lars Lind
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

3.  Genetic variants of the NOTCH3 gene in migraine--a mutation analysis and association study.

Authors:  S Schwaag; S Evers; A Schirmacher; F Stögbauer; E B Ringelstein; G Kuhlenbäumer
Journal:  Cephalalgia       Date:  2006-02       Impact factor: 6.292

4.  Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?

Authors:  Jens P Dreier; Jörg Kleeberg; Gabor Petzold; Josef Priller; Olaf Windmüller; Hans-Dieter Orzechowski; Ute Lindauer; Uwe Heinemann; Karl M Einhäupl; Ulrich Dirnagl
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

5.  Patterns of MRI lesions in CADASIL.

Authors:  H Chabriat; C Levy; H Taillia; M T Iba-Zizen; K Vahedi; A Joutel; E Tournier-Lasserve; M G Bousser
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

6.  Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly.

Authors:  G Breedveld; I F de Coo; M H Lequin; W F M Arts; P Heutink; D B Gould; S W M John; B Oostra; G M S Mancini
Journal:  J Med Genet       Date:  2005-08-17       Impact factor: 6.318

7.  Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.

Authors:  Nils Peters; Tobias Freilinger; Christian Opherk; Thomas Pfefferkorn; Martin Dichgans
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

8.  C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

Authors:  Anna Richards; Arn M J M van den Maagdenberg; Joanna C Jen; David Kavanagh; Paula Bertram; Dirk Spitzer; M Kathryn Liszewski; Maria-Louise Barilla-Labarca; Gisela M Terwindt; Yumi Kasai; Mike McLellan; Mark Gilbert Grand; Kaate R J Vanmolkot; Boukje de Vries; Jijun Wan; Michael J Kane; Hafsa Mamsa; Ruth Schäfer; Anine H Stam; Joost Haan; Paulus T V M de Jong; Caroline W Storimans; Mary J van Schooneveld; Jendo A Oosterhuis; Andreas Gschwendter; Martin Dichgans; Katya E Kotschet; Suzanne Hodgkinson; Todd A Hardy; Martin B Delatycki; Rula A Hajj-Ali; Parul H Kothari; Stanley F Nelson; Rune R Frants; Robert W Baloh; Michel D Ferrari; John P Atkinson
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

9.  Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

Authors:  Tony W Ho; Michel D Ferrari; David W Dodick; Vince Galet; James Kost; Xiaoyin Fan; Heather Leibensperger; Samar Froman; Christopher Assaid; Christopher Lines; Hille Koppen; Paul K Winner
Journal:  Lancet       Date:  2008-11-25       Impact factor: 79.321

10.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

View more
  6 in total

Review 1.  Comorbidity of Migraine.

Authors:  Şebnem Biçakci
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

2.  Orthostatic Cerebral Hypoperfusion Syndrome.

Authors:  Peter Novak
Journal:  Front Aging Neurosci       Date:  2016-02-16       Impact factor: 5.750

Review 3.  Optical Coherence Tomography in Patients with Chronic Migraine: Literature Review and Update.

Authors:  Francisco J Ascaso; Sara Marco; Javier Mateo; Mireya Martínez; Olivia Esteban; Andrzej Grzybowski
Journal:  Front Neurol       Date:  2017-12-13       Impact factor: 4.003

4.  Glaucoma and optical coherence tomography changes in migraine: A comparative cross-sectional study.

Authors:  Gayathri Panicker; Subashini Kaliaperumal; Sunil Narayan; Malavika Mani
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

Review 5.  Stroke and migraine is there a possible comorbidity?

Authors:  Alberto Spalice; Francesca Del Balzo; Laura Papetti; Anna Maria Zicari; Enrico Properzi; Francesca Occasi; Francesco Nicita; Marzia Duse
Journal:  Ital J Pediatr       Date:  2016-04-26       Impact factor: 2.638

Review 6.  Migraine and stroke.

Authors:  Yonghua Zhang; Aasheeta Parikh; Shuo Qian
Journal:  Stroke Vasc Neurol       Date:  2017-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.